This brief, strange encounter with humanity has been for the sake of their own health – and the survival of their kind. These endangered wild monkeys, called golden lion tamarins, have now been vaccinated against yellow fever, part of a pathbreaking campaign to save a threatened species.
“Vaccinating wild animals for the sake of animals, not to protect humans, is novel,” said Luís Paulo Ferraz, president of the nonprofit Golden Lion Tamarin Association.
When yellow fever began to spread in Brazil in 2016, resulting in more than 2,000 human infections and around 750 deaths, it also quickly killed a third of the highly vulnerable tamarins, the majority of them in just a few months. So scientists in Brazil developed a yellow fever vaccine customized for the endangered monkeys.
The inoculation campaign started in 2021, and already more than 300 tamarins have been vaccinated. The first such effort in Brazil, it raises vital questions about how far to go to save a species from extinction.
One of the traditional adages of conservation is “Leave it be.” But in an age when every corner of the globe is touched by human influence – from melting icebergs to fragmented forests to plastic-filled oceans – a new generation of scientists and environmentalists is increasingly calling for more interventionist approaches to save wild animals and ecosystems.
Carlos R. Ruiz-Miranda, a conservation biologist at State University of Northern Rio de Janeiro, is among the scientists who have worked for more than three decades to protect the golden lion tamarins, twice going to their rescue when extinction threatened. He says the vaccinations are the only option left: “Is it too extreme? Give me another alternative.”
Viruses have always abounded in nature. But humans have drastically changed the conditions and impacts of how they spread in wildlife. Epidemics can travel across oceans and borders faster than ever, and species already diminished by habitat loss and other threats are more at risk of being wiped out by outbreaks.
“Human activity is absolutely accelerating disease spread in non-human populations,” said Jeff Sebo, an environmental researcher at New York University, who was not involved in the Brazil project.
Southeastern Brazil was once covered by the rainforest, but today the undulating landscape is an uneven checkerboard of dark green jungle and grassy cow pastures – only 12% of this rainforest remains.
Yet it’s the only place in the world that wild golden lion tamarins live.
The longstanding effort to save the charismatic monkeys – famous for their copper-colored fur and small inquisitive faces framed by silken manes – included a pioneering captive breeding program, coordinated among around 150 zoos worldwide. Many of those animals were then carefully released in Brazil starting in 1984, in cooperation with local landowners.
After the first lab-confirmed death of a tamarin from the virus in 2018, a census of the monkeys revealed the population of wild tamarins had dropped from around 3,700 to 2,500.
“This epidemic moved very quickly from north to south, across the country – no wildlife does that,” said Ruiz-Miranda. “It’s people. They cross vast distances in buses, trains, planes. They bring the disease with them.” Yellow fever is transmitted by mosquitoes, he explained, but highly mobile infected people spread the disease much farther and faster than insects alone.
“We realized that in five years, we could lose the entire population if we did nothing” said Ferraz, of the Golden Lion Tamarin Association.
At the time of the yellow fever outbreak, Marcos da Silva Freire was a deputy director of technological development at Brazil’s Oswaldo Cruz Foundation, which oversees vaccine diagnostics and production in the country.
Freire arranged with the Primate Center of Rio de Janeiro to begin trials of different doses of yellow fever vaccines on about 60 monkeys, close relatives of the tamarins, in January 2018.
A year later, he checked the level of antibodies in their blood. The vaccine appeared to work, without negative side effects. When the team got government approval to begin vaccinating wild monkeys, Freire supervised the first rounds of shots.
So far, they’ve vaccinated more than 300 tamarins and detected no adverse side effects. When they’ve caught and retested monkeys, 90% to 95% have shown immunity — similar to the efficacy of human vaccines.
The outbreak appears to have subsided, and the monitored monkey population has stabilized overall and even increased a little inside the Poço das Antas Biological Reserve.
While authorities elsewhere have inoculated animals to safeguard human health, it’s still very rare for scientists to administer vaccine injections to directly protect an endangered species.
“What are the unintended consequences of vaccination? You can’t always be certain,” said Jacob Negrey, a biologist and primatologist at Wake Forest University’s School of Medicine.
But increasingly scientists are examining the merits of vaccinating endangered wildlife, drawing up plans to potentially vaccinate tigers against canine distemper in Asia, chimpanzees against respiratory diseases in Africa, and koalas against chlamydia in Australia.
“There are people who say we shouldn’t touch nature, that we shouldn’t alter anything. But really, there are no pristine natural habitats left,” said Tony Goldberg, a disease ecologist and veterinarian at the University of Wisconsin-Madison, who supports vaccinating wildlife when it’s safe and practical.
“People are waking up to the magnitude of the problem and realizing they have to do something.”
Follow Christina Larson on Twitter at @larsonchristina.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
